Willow Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.96 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 9.17 M
- Satisfied Charges ₹ 6.00 M
About Willow Pharmaceutical
Willow Pharmaceutical Pvt Ltd (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2006 and has a history of 18 years and nine months. Its registered office is in U T, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.96 M.
The company currently has active open charges totaling ₹9.17 M. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Malik, Ekta Pehal, and Pritender Pehal serve as directors at the Company.
Company Details
- Location U T, Chandigarh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U45202CH2006PTC030108
-
Company No.
030108
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Apr 2006
-
Date of AGM
28 Sep 2013
-
Date of Balance Sheet
31 Mar 2013
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Willow Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Malik
|
Director | 21-Apr-2006 | Current |
|
Ekta Pehal
|
Director | 21-Apr-2006 | Current |
|
Pritender Pehal
|
Director | 20-Jun-2014 | Current |
Financial Performance of Willow Pharmaceutical.
Enhance accessibility to Willow Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Willow Pharmaceutical?
Unlock access to Willow Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.17 M
₹6.00 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.92 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2009 | Canara Bank | ₹9.17 M | Open |
| 19 Sep 2007 | Union Bank Of India | ₹5.00 M | Satisfied |
| 06 Feb 2007 | Canara Bank | ₹1.00 M | Satisfied |
How Many Employees Work at Willow Pharmaceutical?
Unlock and access historical data on people associated with Willow Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Willow Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Willow Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.